Cite

HARVARD Citation

    Hu, Y. et al. (2020). The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data. Bioengineered. 11 (1), pp. 572-581. [Online]. 
  
Back to record